Effects of dietary supplementation of astaxanthin and sesamin on daily fatigue: A randomized, double-blind, placebo-controlled, two-way crossover study

Nutrients

Volumn 10, Issue 3, 2018, Pages

  Imai, Ayano ^a   Oda, Yuriko ^a   Ito, Naoki ^a   Seki, Shinobu ^a   Nakagawa, Kiyotaka ^b   Miyazawa, Teruo ^b   Ueda, Fumitaka ^a  

^a FUJIFILM CORPORATION   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Astaxanthin; Fatigue; Phosphatidylcholine hydroperoxide; Sesame seed extract; Sesamin; Visual analogue scale

Indexed keywords

ASTAXANTHIN; BIOLOGICAL MARKER; PLACEBO; PLASMA PHOSPHATIDYLCHOLINE HYDROPEROXIDE; SESAMIN; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; ANTIOXIDANT; LIGNAN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE HYDROPEROXIDE; XANTHOPHYLL;

ADULT; ARTICLE; AUTONOMIC NERVE; BICYCLE ERGOMETRY; BLOOD ANALYSIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DYSTHYMIA; FATIGUE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PLETHYSMOGRAPHY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SESAME; STUDY DESIGN; TRAIL MAKING TEST; VISUAL ANALOG SCALE; BLOOD; COMPARATIVE STUDY; CONVALESCENCE; DIETARY SUPPLEMENT; DRUG EFFECT; HEALTH STATUS; JAPAN; LIPID PEROXIDATION; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGY; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ANTIOXIDANTS; BIOMARKERS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DIOXOLES; DOUBLE-BLIND METHOD; FEMALE; HEALTH STATUS; HUMANS; JAPAN; LIGNANS; LIPID PEROXIDATION; MALE; MENTAL FATIGUE; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; RECOVERY OF FUNCTION; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; XANTHOPHYLLS;

EID: 85042661541     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10030281     Document Type: Article

References (52)

1. Barclay, J.K.; Hansel, M. Free radicals may contribute to oxidative skeletal muscle fatigue. Can. J. Physiol. Pharmacol. 1991, 69, 279–284. [CrossRef] [PubMed]
2. Sivoňová, M.; Žitňanová, I.; Hlinčíková, L.; Škodáček, I.; Trebatická, J.; Ďuračková, Z. Oxidative stress in university students during examinations. Stress 2004, 7, 183–188. [CrossRef] [PubMed]
3. Logan, A.C.; Wong, C. Chronic fatigue syndrome: Oxidative stress and dietary modifications. Altern. Med. Rev. 2001, 6, 450–459. [PubMed]
4. Manuel y Keenoy, B.; Moorkens, G.; Vertommen, J.; De Leeuw, I. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. 2001, 68, 2037–2049. [CrossRef]
5. Vecchiet, J.; Cipollone, F.; Falasca, K.; Mezzetti, A.; Pizzigallo, E.; Bucciarelli, T.; De Laurentis, S.; Affaitati, G.; De Cesare, D.; Giamberardino, M.A. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci. Lett. 2003, 335, 151–154. [CrossRef]
6. Nakagawa, K.; Kiko, T.; Miyazawa, T.; Carpentero Burdeos, G.; Kimura, F.; Satoh, A.; Miyazawa, T. Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes. Br. J. Nutr. 2011, 105, 1563–1571. [CrossRef] [PubMed]
7. Gutteridge, J.M.C. Lipid-peroxidation and antioxidants as biomarkers of tissue-damage. Clin. Chem. 1995, 41, 1819–1828. [PubMed]
8. Mori, J.; Yokoyama, H.; Sawada, T.; Miyashita, Y.; Nagata, K. Anti-oxidative properties of astaxanthin and related compounds. Mol. Cryst. Liq. Cryst. 2013, 580, 52–57. [CrossRef]
9. Naguib, Y.M.A. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 2000, 48, 1150–1154. [CrossRef] [PubMed]
10. Jaswir, I.; Monsur, H.A. Anti-inflammatory compounds of macro algae origin: A review. J. Med. Plants Res. 2011, 5, 7146–7154. [CrossRef]
11. Tominaga, K.; Hongo, N.; Karato, M.; Yamashita, E. Cosmetic benefits of astaxanthin on humans subjects. Acta Biochim. Pol. 2012, 59, 43–47. [PubMed]
12. Park, J.S.; Chyun, J.H.; Kim, Y.K.; Line, L.L.; Chew, B.P. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr. Metab. 2010, 7, 18. [CrossRef] [PubMed]
13. Hussein, G.; Nakamura, M.; Zhao, Q.; Iguchi, T.; Goto, H.; Sankawa, U.; Watanabe, H. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol. Pharm. Bull. 2005, 28, 47–52. [CrossRef] [PubMed]
14. Shoji, N.; Nakagawa, K.; Asai, A.; Fujita, I.; Hashiura, A.; Nakajima, Y.; Oikawa, S.; Miyazawa, T. LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma. J. Lipid Res. 2010, 51, 2445–2453. [CrossRef] [PubMed]
15. Carvalho, R.H.R.; Galvão, E.L.; Barros, J.Â.C.; Conceição, M.M.; Sousa, E.M.B.D. Extraction, fatty acid profile and antioxidant activity of sesame extract (Sesamum Indicum L.). Braz. J. Chem. Eng. 2012, 29, 409–420. [CrossRef]
16. Hemalatha, S. Ghafoorunissa Sesame lignans enhance the thermal stability of edible vegetable oils. Food Chem. 2007, 105, 1076–1085. [CrossRef]
17. Hongo, N.; Fujishita, M.; Takahashi, Y.; Adachi, Y.; Takahashi, J.; Tominaga, K.; Miura, N. Daily fatigue-reducing effect of astaxathin—A randomized, placebo-controlled, double-blind, parallel-group study. Jpn. Pharmacol. Ther. 2017, 45, 61–72.
18. Takemoto, D.; Yasutake, Y.; Tomimori, N.; Ono, Y.; Shibata, H.; Hayashi, J. Sesame lignans and vitamin E supplementation improve subjective statuses and anti-oxidative capacity in healthy humans with feelings of daily fatigue. Glob. J. Health Sci. 2015, 7, 1–10. [CrossRef] [PubMed]
19. Odebarg, J.M. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur. J. Pharm. Sci. 2003, 19, 299–304. [CrossRef]
20. Osterlie, M.; Bjerkeng, B.; Liaaen-Jensen, S. Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J. Nutr. Biochem. 2000, 11, 482–490. [CrossRef]
21. 14 C]sesamin in rats. Mol. Nutr. Food Res. 2017, 61, 1600844. [CrossRef] [PubMed]
22. Hirayama, Y. Development of guideline of clinical evaluation of anti-fatigue. J. Clin. Exp. Med. 2009, 228, 733–736. (In Japanese)
23. Chalder, T.; Berelowitz, G.; Pawlikowska, T.; Watts, L.; Wessely, S.; Wright, D.; Wallace, E.P. Development of a fatigue scale. J. Psychosom. Res. 1993, 37, 147–153. [CrossRef]
24. Yokoyama, K.; Watanabe, K. Japanese Translation of POMS 2: Profile of Mood States Second Edition; Kaneko Shobo: Tokyo, Japan, 2015.
25. Yamamoto, Y.; Tanaka, H.; Takase, M.; Shirakawa, S. Standardization of revised version of OSA sleep inventory for middle age and aged. Brain Sci. Ment. Disord. 1999, 10, 401–409.
26. Tanaka, M.; Shigihara, Y.; Fujii, H.; Hirayama, Y.; Watanabe, Y. Effect of CBEX-Dr-containing drink on physical fatigue in healthy volunteers. Jpn. Pharmacol. Ther. 2008, 36, 199–212.
27. Ataka, S.; Tanaka, M.; Nozaki, S.; Mizuma, H.; Mizuno, K.; Tahara, T.; Sugino, T.; Shirai, T.; Kajimoto, Y.; Kuratsune, H.; et al. Effects of oral administration of caffeine and D-ribose on mental fatigue. Nutrition 2008, 24, 233–238. [CrossRef] [PubMed]
28. Lorish, C.D.; Maisiak, R. The face scale: A brief, nonverbal method for assessing patient mood. Arthritis Rheumatol. 1986, 29, 906–909. [CrossRef]
29. Takada, M.; Ebara, T.; Sakai, Y. The acceleration plethysmography system as a new physiological technology for evaluating autonomic modulations. Health Eval. Promot. 2008, 35, 373–377. [CrossRef]
30. Kirchner, W.K. Age differences in short-term retention of rapidly changing information. J. Exp. Psychol. 1958, 55, 352–358. [CrossRef] [PubMed]
31. Mizuno, K.; Watanabe, Y. Utility of an advanced trail making test as a neuropsychological tool for an objective evaluation of work efficiency during mental fatigue. In Fatigue Science for Human Health; Springer: New York, NY, USA, 2008; pp. 47–54.
32. Nakamura, Y.; Mutoh, Y.; Miyashita, M. Determination of the peak power output during maximal brief pedalling bouts. J. Sports Sci. 1985, 3, 181–187. [CrossRef] [PubMed]
33. Takada, H.; Okino, K.; Niwa, Y. An evaluation method for heart rate variability, by using acceleration plethysmography. Health Eval. Promot. 2004, 31, 547–555. [CrossRef]
34. Malik, M.; Bigger, J.T.; Camm, A.J.; Kleiger, R.E.; Malliani, A.; Moss, A.J.; Schwartz, P.J. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Eur. Heart J. 1996, 17, 354–381. [CrossRef]
35. Folch, J.; Lees, M.; Stanley, G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [CrossRef] [PubMed]
36. Kato, S.; Nakagawa, K.; Suzuki, Y.; Asai, A.; Nagao, M.; Nagashima, K.; Oikawa, S.; Miyazawa, T. Liquid chromatography-tandem mass spectrometry determination of human plasma 1-palmitoyl-2-hydroperoxyoctadecadienoyl-phosphatidylcholine isomers via promotion of sodium adduct formation. Anal. Biochem. 2015, 471, 51–60. [CrossRef] [PubMed]
37. Smith, M.J.; Conway, F.T.; Karsh, B.-T. Occupational stress in human computer interaction. Ind. Health 1999, 37, 157–173. [CrossRef] [PubMed]
38. Shen, H.; Kuo, C.-C.; Chou, J.; Delvolve, A.; Jackson, S.N.; Post, J.; Woods, A.S.; Hoffer, B.J.; Wang, Y.; Harvey, B.K. Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 2009, 23, 1958–1968. [CrossRef] [PubMed]
39. Zhang, X.-S.; Zhang, X.; Wu, Q.; Li, W.; Wang, C.-X.; Xie, G.-B.; Zhou, X.-M.; Shi, J.-X.; Zhou, M.-L. Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage. J. Surg. Res. 2014, 192, 206–213. [CrossRef] [PubMed]
40. Zhang, X.-S.; Zhang, X.; Zhou, M.-L.; Zhou, X.-M.; Li, N.; Li, W.; Cong, Z.-X.; Sun, Q.; Zhuang, Z.; Wang, C.-X.; et al. Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage. J. Neurosurg. 2014, 121, 42–54. [CrossRef] [PubMed]
41. Lee, D.-H.; Kim, C.-S.; Lee, Y.J. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem. Toxicol. 2011, 49, 271–280. [CrossRef] [PubMed]
42. Katakura, Y.; Totsuka, M.; Imabayashi, E.; Matsuda, H.; Hisatsune, T. Anserine/carnosine supplementation suppresses the expression of the inflammatory chemokine CCL24 in peripheral blood mononuclear cells from elderly people. Nutrients 2017, 9, 1199. [CrossRef] [PubMed]
43. Yamano, E.; Tanaka, M.; Ishii, A.; Tsuruoka, N.; Abe, K.; Watanabe, Y. Effects of chicken essence on recovery from mental fatigue in healthy males. Med. Sci. Monit. 2013, 19, 540–547. [CrossRef] [PubMed]
44. Klimas, N.G.; Koneru, A.O.B. Chronic fatigue syndrome: Inflammation, immune function, and neuroendocrine interactions. Curr. Rheumatol. Rep. 2007, 9, 482–487. [CrossRef] [PubMed]
45. Ikeuchi, M.; Koyama, T.; Takahashi, J.; Yazawa, K. Effects of astaxanthin supplementation on exercise-induced fatigue in mice. Biol. Pharm. Bull. 2006, 29, 2106–2110. [CrossRef] [PubMed]
46. Aoi, W.; Naito, Y.; Takanami, Y.; Ishii, T.; Kawai, Y.; Akagiri, S.; Kato, Y.; Osawa, T.; Yoshikawa, T. Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem. Biophys. Res. Commun. 2007, 366, 892–897. [CrossRef] [PubMed]
47. Ikeda, T.; Nishijima, Y.; Shibata, H.; Kiso, Y.; Ohnuki, K.; Fushiki, T.; Moritani, T. Protective effect of sesamin administration on exercise-induced lipid peroxidation. Int. J. Sports Med. 2003, 24, 530–534. [CrossRef] [PubMed]
48. Kiso, Y. Antioxidative roles of sesamin, a functional lignan in sesame seed, and it’s effect on lipid- and alcohol-metabolism in the liver: A DNA microarray study. Biofactors 2004, 21, 191–196. [CrossRef] [PubMed]
49. Nakai, M.; Harada, M.; Nakahara, K.; Akimoto, K.; Shibata, H.; Miki, W.; Kiso, Y. Novel antioxidative metabolites in rat liver with ingested sesamin. J. Agric. Food Chem. 2003, 51, 1666–1670. [CrossRef] [PubMed]
50. Chavali, S.R.; Zhong, W.W.; Forse, R.A. Dietary α-linolenic acid increases TNF-α, and decreases IL-6, IL-10 in response to LPS: Effects of sesamin on the ∆-5 desaturation of ω6 and ω3 fatty acids in mice. Prostaglandins Leukot. Essent. Fat. Acids 1998, 58, 185–191. [CrossRef]
51. Hou, R.; Chen, H.; Tzen, J.; Jeng, K. Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport 2003, 14, 1815–1819. [CrossRef] [PubMed]
52. Cheng, F.C.; Jinn, T.R.; Hou, R.C.; Tzen, J.T. Neuroprotective effects of sesamin and sesamolin on gerbil brain in cerebral ischemia. Int. J. Biomed. Sci. 2006, 2, 284–288. [PubMed]